MedPath

M.D. ANDERSON CANCER CENTER

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Smoking Cessation for Depressed Smokers

Phase 1
Active, not recruiting
Conditions
Smoking
Depression
Interventions
Behavioral: Smoking Cessation Treatment
Behavioral: CBASP
First Posted Date
2007-07-02
Last Posted Date
2025-05-22
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
91
Registration Number
NCT00494728
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Phase 2
Completed
Conditions
Lung Cancer
Interventions
Radiation: Proton Radiotherapy
First Posted Date
2007-07-02
Last Posted Date
2019-02-06
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
84
Registration Number
NCT00495170
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Effects of Rocking on Postoperative Ileus Duration Study

Early Phase 1
Completed
Conditions
Abdominal Cancer
Interventions
Other: Rocking Chair Intervention
First Posted Date
2007-07-02
Last Posted Date
2012-08-07
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
66
Registration Number
NCT00494806
Locations
🇺🇸

U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Pre-Surgical Qigong Therapy for Women With Breast Cancer

Completed
Conditions
Breast Cancer
Interventions
Other: Qigong
First Posted Date
2007-07-02
Last Posted Date
2018-08-15
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
7
Registration Number
NCT00495209
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Phase 2
Active, not recruiting
Conditions
Metastatic Head and Neck Squamous Cell Carcinoma
Metastatic Squamous Cell Carcinoma of the Larynx
Metastatic Squamous Cell Carcinoma of the Oral Cavity
Metastatic Squamous Cell Carcinoma of the Oropharynx
Recurrent Oropharyngeal Squamous Cell Carcinoma
Metastatic Squamous Cell Carcinoma of the Hypopharynx
Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Hypopharyngeal Squamous Cell Carcinoma
Recurrent Laryngeal Squamous Cell Carcinoma
Recurrent Oral Cavity Squamous Cell Carcinoma
Interventions
First Posted Date
2007-06-29
Last Posted Date
2025-05-31
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
48
Registration Number
NCT00494182
Locations
🇺🇸

M D Anderson Cancer Center, Houston, Texas, United States

CEP-701 for PH-negative Myelofibrosis

Phase 2
Completed
Conditions
Myelofibrosis
Leukemia
Interventions
First Posted Date
2007-06-29
Last Posted Date
2012-06-25
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
27
Registration Number
NCT00494585
Locations
🇺🇸

The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States

Zevalin (Ibritumomab Tiuxetan) for Early Stage Indolent Lymphomas

Phase 2
Completed
Conditions
Lymphoma
Interventions
First Posted Date
2007-06-28
Last Posted Date
2022-09-15
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
31
Registration Number
NCT00493467
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Recruiting
Conditions
Pelvic Cancer
Abdominal Cancer
Interventions
Other: Cardiopulmonary Exercise Testing (CPET)
First Posted Date
2007-06-28
Last Posted Date
2025-01-15
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
200
Registration Number
NCT00493688
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Delirium Recall in Advanced Cancer Patients

Completed
Conditions
Advanced Cancer
Delirium
Interventions
Behavioral: Questionnaire
First Posted Date
2007-06-28
Last Posted Date
2012-07-30
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
200
Registration Number
NCT00493714
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer

Completed
Conditions
Breast Cancer
Interventions
Procedure: Blood Sample
First Posted Date
2007-06-28
Last Posted Date
2012-07-31
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
660
Registration Number
NCT00493350
Locations
🇺🇸

U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath